ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc. Financials - Benzinga

SPY765.80+0.02%QQQ737.05+0.07%BTC/USD82,969.61−0.58%DIA514.14+0.02%GLD378.31+0.11%TLT78.69+0.09%

ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc.

ZIVOOTCID

Trade with Public

Trade with Public

$1.10

At close: Dec 4, 4:00 PM EST

$11.95

10.85986.36%

After Hours: Dec 1, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc. Financials

ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc. (ZIVO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Zivo Bioscience Q2 EPS $(0.43) Misses $(0.41) Estimate, Sales $53.400K Miss $150.000K Estimate

Zivo Bioscience (NASDAQ:ZIVO) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.41) by 4.88 percent. This is a 84.53 percent increase over losses of $(2.78) per share from

Benzinga Newsdesk

Mid-Morning Market Update: Markets Mixed; Nike Sales Miss Views

Following the market opening Friday, the Dow traded up 0.15% to 34,817.63 while the NASDAQ fell 0.36% to 14,998.13. The S&P also rose, gaining 0.08% to 4,452.44.

Lisa Levin

Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge

Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67.

Lisa Levin

Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher

Midway through trading Monday, the Dow traded down 1.51% to 34,063.71 while the NASDAQ fell 2.13% to 14,723.20. The S&P also fell, dropping 1.64% to 4,360.41.

Lisa Levin

Mid-Morning Market Update: Markets Open Lower; Brooks Automation Divests Semiconductor Business For $3B

Following the market opening Monday, the Dow traded down 1.42% to 34,093.46 while the NASDAQ fell 1.86% to 14,763.93. The S&P also fell, dropping 1.54% to 4,364.65.

Lisa Levin

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)

Shanthi Rexaline

© 2026 Benzinga | All Rights Reserved